Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Oct 2011

Bhatia Smita

Abstract excerpt

Clear and unambiguous associations have been established between therapeutic exposures and specific complications. However, considerable interindividual variability is observed in the risk of developing an outcome for a given therapeutic exposure. Genetic predisposition and especially its interaction with therapeutic exposures can potentially exacerbate the toxic effect of treatment on normal tissues and organ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Comorbidity
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Neoplasms

Share to Prognosis

Share to Survival Rate

Share to Survivors

Source

Open in PubMed Open full text

Identifiers

PMID: 21980013
DOI: 10.1158/1055-9965.EPI-11-0659
PMCID: PMC3191885

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors.PMID 21980013Read ↗

Chronic health conditions in childhood cancer survivors: is it all treatment-related--or do genetics play a role?Semantic proximity Read ↗

Genetic Background in Patients with Cancer Therapy-Induced CardiomyopathySemantic proximity Read ↗

From Genes to Personalized Cancer Care: A Systematic Review of Toxicity-Associated Genetic Variants in Solid Tumor TreatmentsSemantic proximity Read ↗

Common genetic predisposition for heart failure and cancer.Semantic proximity Read ↗

Finding the genetic determinants of adverse reactions to radiotherapy.Semantic proximity Read ↗

The genetic underpinnings of anthracycline-induced cardiomyopathy predisposition.Semantic proximity Read ↗

Genetic Susceptibility and Mechanisms Underlying the Pathogenesis of Anthracycline-Associated Cardiotoxicity.Semantic proximity Read ↗

Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.Semantic proximity Read ↗

Genetic risk prediction: individualized variability in susceptibility to toxicants.Semantic proximity Read ↗

Integrative epidemiology: from risk assessment to outcome prediction.Semantic proximity Read ↗

Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.Semantic proximity Read ↗

Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.